These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Stimulation of testosterone production in rat Leydig cells by aldosterone is mineralocorticoid receptor mediated. Ge RS; Dong Q; Sottas CM; Latif SA; Morris DJ; Hardy MP Mol Cell Endocrinol; 2005 Nov; 243(1-2):35-42. PubMed ID: 16188378 [TBL] [Abstract][Full Text] [Related]
24. Insulin treatment partially prevents cognitive and hippocampal alterations as well as glucocorticoid dysregulation in early-onset insulin-deficient diabetic rats. Marissal-Arvy N; Campas MN; Semont A; Ducroix-Crepy C; Beauvieux MC; Brossaud J; Corcuff JB; Helbling JC; Vancassel S; Bouzier-Sore AK; Touyarot K; Ferreira G; Barat P; Moisan MP Psychoneuroendocrinology; 2018 Jul; 93():72-81. PubMed ID: 29702445 [TBL] [Abstract][Full Text] [Related]
25. 11Beta-hydroxysteroid dehydrogenase in the Dahl rat. Franco-Saenz R; Tokita Y; Latif S; Morris DJ Am J Hypertens; 1997 Sep; 10(9 Pt 1):1004-9. PubMed ID: 9324106 [TBL] [Abstract][Full Text] [Related]
26. Obese Zucker rats have reduced mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 1 expression in hippocampus-implications for dysregulation of the hypothalamic-pituitary-adrenal axis in obesity. Mattsson C; Lai M; Noble J; McKinney E; Yau JL; Seckl JR; Walker BR Endocrinology; 2003 Jul; 144(7):2997-3003. PubMed ID: 12810555 [TBL] [Abstract][Full Text] [Related]
27. 11{beta}-Hydroxysteroid dehydrogenase 2 in rat leydig cells: its role in blunting glucocorticoid action at physiological levels of substrate. Ge RS; Dong Q; Niu EM; Sottas CM; Hardy DO; Catterall JF; Latif SA; Morris DJ; Hardy MP Endocrinology; 2005 Jun; 146(6):2657-64. PubMed ID: 15761036 [TBL] [Abstract][Full Text] [Related]
28. 11beta-hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation. Zhang ZH; Kang YM; Yu Y; Wei SG; Schmidt TJ; Johnson AK; Felder RB Hypertension; 2006 Jul; 48(1):127-33. PubMed ID: 16717146 [TBL] [Abstract][Full Text] [Related]
29. Role of 11beta-hydroxysteroid dehydrogenase 2 renal activity in potassium homeostasis in rats with chronic renal failure. Yeyati NL; Altuna ME; Damasco MC; Mac Laughlin MA Braz J Med Biol Res; 2010 Jan; 43(1):52-6. PubMed ID: 20027486 [TBL] [Abstract][Full Text] [Related]
30. Tissue-specific messenger ribonucleic acid expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor within rat placenta suggests exquisite local control of glucocorticoid action. Waddell BJ; Benediktsson R; Brown RW; Seckl JR Endocrinology; 1998 Apr; 139(4):1517-23. PubMed ID: 9528929 [TBL] [Abstract][Full Text] [Related]
31. Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression. Cavallari LH; Fashingbauer LA; Camp JR; King ST; Geenen DL J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):146-53. PubMed ID: 18957385 [TBL] [Abstract][Full Text] [Related]
32. Hypoxia causes down-regulation of 11 beta-hydroxysteroid dehydrogenase type 2 by induction of Egr-1. Heiniger CD; Kostadinova RM; Rochat MK; Serra A; Ferrari P; Dick B; Frey BM; Frey FJ FASEB J; 2003 May; 17(8):917-9. PubMed ID: 12626438 [TBL] [Abstract][Full Text] [Related]
33. Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats. Hofni A; El-Moselhy MA; Taye A; Khalifa MM Eur J Pharmacol; 2014 Dec; 744():173-82. PubMed ID: 25446917 [TBL] [Abstract][Full Text] [Related]
34. The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2. Odermatt A; Arnold P; Frey FJ J Biol Chem; 2001 Jul; 276(30):28484-92. PubMed ID: 11350956 [TBL] [Abstract][Full Text] [Related]
35. Glucocorticoid receptor, mineralocorticoid receptors, 11 beta-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies. Roland BL; Krozowski ZS; Funder JW Mol Cell Endocrinol; 1995 Apr; 111(1):R1-7. PubMed ID: 7649347 [TBL] [Abstract][Full Text] [Related]
36. The role of 11beta-hydroxysteroid dehydrogenase in steroid hormone specificity. Náray-Fejes-Tóth A; Colombowala IK; Fejes-Tóth G J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):311-6. PubMed ID: 9699885 [TBL] [Abstract][Full Text] [Related]
37. The possible roles of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in cardiac fibrosis in the spontaneously hypertensive rat. Konishi A; Tazawa C; Miki Y; Darnel AD; Suzuki T; Ohta Y; Suzuki T; Tabayashi K; Sasano H J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):439-42. PubMed ID: 12943733 [TBL] [Abstract][Full Text] [Related]
38. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes. Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316 [TBL] [Abstract][Full Text] [Related]
39. The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero. Bertram C; Trowern AR; Copin N; Jackson AA; Whorwood CB Endocrinology; 2001 Jul; 142(7):2841-53. PubMed ID: 11416003 [TBL] [Abstract][Full Text] [Related]
40. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Miric G; Dallemagne C; Endre Z; Margolin S; Taylor SM; Brown L Br J Pharmacol; 2001 Jul; 133(5):687-94. PubMed ID: 11429393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]